pharma · Acute Myeloid Leukemia · Narcolepsy · JAZZ
Jazz Pharmaceuticals Ireland
Jazz Pharmaceuticals Ireland Limited
Jazz Pharmaceuticals Ireland clinical programs — 58 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Waterloo Exchange, Waterloo Road, Dublin, 4, IE
- Founded
- 2003
- Employees
- 3,631
- Programs
- 208
- Drugs
- 91
- Patents
- 89
Jazz Pharmaceuticals Ireland projects
58 ClinicalTrials.gov programs sponsored by Jazz Pharmaceuticals Ireland.
Jazz Pharmaceuticals Ireland has 58 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Xyrem
Jazz Pharmaceuticals Ireland Limited
Narcolepsy
1 trial -
Xyrem (sodium oxybate) oral solution
Jazz Pharmaceuticals Ireland Limited
Narcolepsy
1 trial -
Xyrem®
Jazz Pharmaceuticals Ireland Limited
Fibromyalgia
2 trials -
ZWI-ZW25-301
Jazz Pharmaceuticals Ireland Limited
Gastroesophageal Adenocarcinoma (GEA)
1 trial -
Zanidatamab
Jazz Pharmaceuticals Ireland Limited
Metastatic HER2-positive Breast Cancer
1 trial -
Zanidatamab
Jazz Pharmaceuticals Ireland Limited
Biliary Tract Cancer
1 trial -
a benzodiazepine drug
Jazz Pharmaceuticals Ireland Limited
Anxiety Disorder
1 trial -
experimental anti-anxiety drug
Jazz Pharmaceuticals Ireland Limited
Anxiety Disorder
1 trial -
placebo
Jazz Pharmaceuticals Ireland Limited
Fibromyalgia
1 trial -
supersaturated calcium-phosphate
Jazz Pharmaceuticals Ireland Limited
Oral Complaints
1 trial
Frequently asked questions
How many clinical projects does Jazz Pharmaceuticals Ireland have?
58 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.